| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/05/2003 | CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase |
| 06/04/2003 | EP1315965A2 Methods and compositions for in vitro targeting |
| 06/04/2003 | EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/04/2003 | EP1315830A2 Compositions and methods for targeting peptides in humans in vivo |
| 06/04/2003 | EP1315738A1 Extended native chemical ligation |
| 06/04/2003 | EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 06/04/2003 | EP0789578B1 Multicatalytic protease inhibitors |
| 06/03/2003 | US6573409 Prepared from 3,3-dimethylbutanol. Intermediate 3,3-dimethylbutanol is obtained by reacting ethylene, isopropylene and sulfuric acid to produce a 3,3- dimethylbutyl ester which is hydrolyzed to the alcohol. |
| 06/03/2003 | US6573259 Inhibitors of interleukin-1β converting enzyme |
| 06/03/2003 | CA2145523C Polypeptides involved in streptogramineae biosynthesis; nucleotide sequences coding said polypeptides and their use |
| 06/03/2003 | CA2076424C Phosphoinositol-glycan-peptide with insulin-like action |
| 05/30/2003 | WO2003044045A2 Peptides promoting cell adherence, growth and secretion |
| 05/30/2003 | WO2003044044A1 Novel peptide having angiotensin convertase inhibitory effect |
| 05/30/2003 | WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 05/30/2003 | WO2003043631A2 Method for identification of tumor targeting enzymes |
| 05/30/2003 | WO2003043518A2 Methods and products for oral care |
| 05/30/2003 | WO2002059293A3 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 05/30/2003 | CA2468170A1 Method for identification of tumor targeting enzymes |
| 05/30/2003 | CA2467747A1 Methods and products for oral care |
| 05/30/2003 | CA2467181A1 Peptides promoting cell adherence, growth and secretion |
| 05/29/2003 | US20030100770 D-proline derivatives |
| 05/29/2003 | US20030100768 Imidazolidinones and their related derivatives as hepatitis C virus NS3 protease inhibitors |
| 05/29/2003 | US20030100750 Process for solid supported synthesis of pyruvate-derived compounds |
| 05/29/2003 | US20030100561 Treatment of insulin resistance with growth hormone secretagogues |
| 05/29/2003 | US20030100550 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 05/29/2003 | US20030100512 Gamma-secretase inhibitors |
| 05/29/2003 | US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer |
| 05/29/2003 | US20030100508 Carbohydrate epitope mimic compounds and uses thereof |
| 05/29/2003 | US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
| 05/28/2003 | EP1314360A1 Process for producing a stable aspartame slurry and testing method for determining its stability |
| 05/28/2003 | EP1313872A1 A method of producing fr901228 |
| 05/28/2003 | EP1313730A1 Pyrrolidine derivatives and their use as chymase inhibitor |
| 05/28/2003 | EP1163239B1 Modified amino-acid amides as cgrp antagonists |
| 05/28/2003 | EP1106626B1 Process for the preparation of regular glycopeptides |
| 05/28/2003 | EP0981358B1 Dolastatin-15 derivatives in combination with taxanes |
| 05/28/2003 | EP0968227B1 Dimeric cationic lipids on dicystine basis |
| 05/28/2003 | EP0788509B1 Therapeutic peptide derivatives |
| 05/28/2003 | EP0788360B1 Boronic ester and acid compounds, synthesis and uses |
| 05/28/2003 | CN1420867A Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 05/27/2003 | US6570070 Generating herbicide resistant plants; obtain plant, incubate with vector coding preferential enzymatic polypeptides, transform plant, propagate, monitor transgentic plants response to herbicides |
| 05/27/2003 | US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors |
| 05/27/2003 | US6570012 Derivatives of octahydro-6, 10-dioxo-6H-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, useful for preperation of therapeutically active compounds |
| 05/27/2003 | US6569998 Synthetic glycosulfopeptides and methods of synthesis thereof |
| 05/27/2003 | US6569993 Process for the preparation of resin-bound cyclic peptides |
| 05/27/2003 | US6569876 Method and structure for inhibiting activity of serine elastases |
| 05/27/2003 | US6569854 Streptogramin derivatives, their preparation and compositions containing them |
| 05/27/2003 | US6569851 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/27/2003 | US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease |
| 05/27/2003 | US6569834 Elucidation and synthesis of antineoplastic tetrapeptide w-aminoalkyl-amides |
| 05/27/2003 | US6569402 Vitronectin receptor antagonist pharmaceuticals |
| 05/22/2003 | WO2003042237A1 Peptide derivative, pharmaceutically acceptable salt thereof, process for producing the same, and use thereof |
| 05/22/2003 | WO2003042197A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 05/22/2003 | WO2003041729A1 Ptp1b inhibitors and ligands |
| 05/22/2003 | WO2003011115A3 Peptide-based multimeric targeted contrast agents |
| 05/22/2003 | WO2002100353A3 Cd10-activated prodrug compounds |
| 05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 05/22/2003 | US20030097011 Novel carbamate-based cationic lipids |
| 05/22/2003 | US20030096956 Process for producing kiss-1 peptide |
| 05/22/2003 | US20030096953 Protein mixture for use in the detection of microbiocides |
| 05/22/2003 | US20030096875 Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 05/22/2003 | US20030096857 Novel antidiabetic agents |
| 05/22/2003 | US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 05/22/2003 | US20030096793 Inhibit protease enzymes; Benzyl 5-(benzoylamino)-4,4-dihydroxy-7- methyl-4-sila-octanamide, for example can be used to inhibit HIV protease in the treatment of AIDS |
| 05/22/2003 | US20030096759 Novel elastase inhibitors |
| 05/22/2003 | US20030096354 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 05/22/2003 | US20030096048 Processes for preparing an aspartame slurry |
| 05/22/2003 | CA2467391A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 05/22/2003 | CA2465080A1 Peptide derivative and pharmaceutically acceptable salts thereof, and production process and use thereof |
| 05/22/2003 | CA2461481A1 Ptp1b inhibitors and ligands |
| 05/21/2003 | EP1312612A1 Cyclic peptide derivative |
| 05/21/2003 | EP1312609A1 Boronic ester and acid compounds, synthesis and uses |
| 05/21/2003 | EP1311535A1 Metal ion assisted n- n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester isomer resolution |
| 05/21/2003 | EP1311292A2 Vitronectin receptor antagonist pharmaceuticals |
| 05/21/2003 | EP1311280A2 Cell internalized peptide-drug conjugates |
| 05/21/2003 | CN1108796C Use of anticancer material and production method of said anti-cancer material |
| 05/20/2003 | US6566493 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties |
| 05/20/2003 | US6566379 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 05/20/2003 | US6566338 Administering caspase inhibitor for therapy of oral mucositis, gastrointestinal mucositis, bladder mucositis or proctitis resulting from chemotherapy or radiation therapy of cancer in an animal |
| 05/20/2003 | US6566337 Compounds with growth hormone releasing properties |
| 05/20/2003 | US6566335 Administering a peptide derivative for mobilizing hematopoietic progenitor cells from bone marrow into peripheral blood |
| 05/20/2003 | US6566330 Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| 05/20/2003 | US6566327 Histogranin peptides and their analgesic use |
| 05/20/2003 | US6566129 Transformed cells useful for the control of pests |
| 05/20/2003 | US6566077 Qualitative or quantitative analysis of immunoglobulin; generate solid support, incubate with immunoglobulin mixture, wash microtiter plate, detect complexed immunoglobulin |
| 05/20/2003 | CA2322944C Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors |
| 05/20/2003 | CA2099994C Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 05/15/2003 | WO2003040288A2 Isotopically coded affinity markers 3 |
| 05/15/2003 | WO2003040174A2 Substituted amino ketone compounds |
| 05/15/2003 | WO2003040173A1 ANTAGONISTS FOR α4-INTEGRINS |
| 05/15/2003 | WO2003040172A2 Methods and reagents for peptide-bir interaction screens |
| 05/15/2003 | WO2003040137A1 Dimeric compounds and their use as anti-viral agents |
| 05/15/2003 | WO2003039454A2 Beta-secretase inhibitors and methods of use |
| 05/15/2003 | WO2002094856A3 Gpe analogs and peptidomimetics |
| 05/15/2003 | WO2002088318A3 Lipid-comprising drug delivery complexes and methods for their production |
| 05/15/2003 | WO2002057298A3 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 05/15/2003 | WO2002004423A9 Thrombin inhibitors comprising an aminoisoquinoline group |
| 05/15/2003 | US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases |
| 05/15/2003 | US20030092630 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases |
| 05/15/2003 | US20030092629 Inhibitors of memapsin 2 and use thereof |
| 05/15/2003 | US20030092609 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others |